Skip to main content Accesibility Help

A 4-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder

  • K. A. Phillips (a1) (a2), W. Menard (a1), E. Quinn (a3), E. R. Didie (a1) (a2) and R. L. Stout (a2) (a4)...

This report prospectively examines the 4-year course, and predictors of course, of body dysmorphic disorder (BDD), a common and often severe disorder. No prior studies have prospectively examined the course of BDD in individuals ascertained for BDD.


The Longitudinal Interval Follow-Up Evaluation (LIFE) assessed weekly BDD symptoms and treatment received over 4 years for 166 broadly ascertained adults and adolescents with current BDD at intake. Kaplan–Meier life tables were constructed for time to remission and relapse. Full remission was defined as minimal or no BDD symptoms, and partial remission as less than full DSM-IV criteria, for at least 8 consecutive weeks. Full relapse and partial relapse were defined as meeting full BDD criteria for at least 2 consecutive weeks after attaining full or partial remission respectively. Cox proportional hazards regression examined predictors of remission and relapse.


Over 4 years, the cumulative probability was 0.20 for full remission and 0.55 for full or partial remission from BDD. A lower likelihood of full or partial remission was predicted by more severe BDD symptoms at intake, longer lifetime duration of BDD, and being an adult. Among partially or fully remitted subjects, the cumulative probability was 0.42 for subsequent full relapse and 0.63 for subsequent full or partial relapse. More severe BDD at intake and earlier age at BDD onset predicted full or partial relapse. Eighty-eight percent of subjects received mental health treatment during the follow-up period.


In this observational study, BDD tended to be chronic. Several intake variables predicted greater chronicity of BDD.

Corresponding author
*Address for correspondence: K. A. Phillips, M.D., Rhode Island Hospital, Coro Center West, Suite 2.030, 1 Hoppin Street, Providence, RI 02903, USA. (Email:
Hide All
Bjornsson, AS, Dyck, I, Moitra, E, Stout, RL, Weisberg, RB, Keller, MB, Phillips, KA (2011). The clinical course of body dysmorphic disorder in the Harvard/Brown Anxiety Research Project (HARP). Journal of Nervous and Mental Disease 199, 5557.
Bruce, SE, Yonkers, KA, Otto, MW, Eisen, JL, Weisberg, RB, Pagano, M, Shea, MT, Keller, MB (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. American Journal of Psychiatry 162, 11791187.
Buhlmann, U, Glaesmer, H, Mewes, R, Fama, JM, Wilhelm, S, Brahler, E, Rief, W (2010). Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Research 178, 171175.
Buhlmann, U, McNally, RJ, Etcoff, NL, Tuschen-Caffier, B, Wilhelm, S (2004). Emotion recognition deficits in body dysmorphic disorder. Journal of Psychiatric Research 38, 201206.
Coryell, W, Leon, A, Winokur, G, Endicott, J, Keller, M, Akiskal, H, Solomon, D (1996). Importance of psychotic features to long-term course in major depressive disorder. American Journal of Psychiatry 153, 483489.
Cox, DR (1972). Regression models and life-tables. Journal of the Royal Statistical Society, Series B 34, 187220.
Eisen, JL, Phillips, KA, Baer, L, Beer, DA, Atala, KD, Rasmussen, SA (1998). The Brown Assessment of Beliefs Scale: reliability and validity. American Journal of Psychiatry 155, 102108.
Eisen, JL, Pinto, A, Mancebo, MC, Dyck, IR, Orlando, ME, Rasmussen, SA (2010). A 2-year prospective follow-up study of the course of obsessive-compulsive disorder. Journal of Clinical Psychiatry 71, 10331039.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders: Non-Patient Edition (SCID-N/P). New York State Psychiatric Institute: New York.
Flint, AJ, Rifat, SL (1998). Two-year outcome of psychotic depression in late life. American Journal of Psychiatry 155, 178183.
Goisman, RM, Warshaw, MG, Peterson, LG, Rogers, MP, Cuneo, P, Hunt, MF, Tomlin-Albanese, JM, Kazim, A, Gollan, JK, Epstein-Kaye, T, Reich, JH, Keller, MB (1994). Panic, agoraphobia, and panic disorder with agoraphobia. Data from a multicenter anxiety disorders study. Journal of Nervous and Mental Disease 182, 7279.
Gunderson, JG, Stout, RL, McGlashan, TH, Shea, MT, Morey, LC, Grilo, CM, Zanarini, MC, Yen, S, Markowitz, JC, Sanislow, C, Ansell, E, Pinto, A, Skodol, AE (2011). Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Archives of General Psychiatry 68, 827837.
Gunstad, J, Phillips, KA (2003). Axis I comorbidity in body dysmorphic disorder. Comprehensive Psychiatry 44, 270276.
Ipser, J, Sander, C, Stein, D (2009). Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database of Systematic Reviews (Online) 21, CD005332.
Keller, MB (2006). Social anxiety disorder clinical course and outcome: review of Harvard/Brown Anxiety Research Project (HARP) findings. Journal of Clinical Psychiatry 67 (Suppl. 12), 1419.
Keller, MB, Lavori, PW, Coryell, W, Endicott, J, Meuller, TI (1998). Bipolar I: a five-year perspective follow-up. Journal of Nervous and Mental Disease 181, 238245.
Keller, MB, Lavori, PW, Friedman, B, Nielsen, E (1987). The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44, 540548.
Koran, LM, Abujaoude, E, Large, MD, Serpe, RT (2008). The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectrums 13, 316322.
Mancuso, S, Knoesen, N, Castle, DJ (2010). Delusional vs nondelusional body dysmorphic disorder. Comprehensive Psychiatry 51, 177182.
Nagy, LM, Krystal, JH, Woods, SW, Charney, DS (1989). Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Archives of General Psychiatry 46, 993999.
NICE (2006). Core Interventions in the Treatment of Obsessive Compulsive Disorder and Body Dysmorphic Disorder. National Institute for Health and Clinical Excellence (NICE) Clinical Guideline CG31 ( Accessed June 2011.
Noyes, R Jr., Reich, J, Christiansen, J, Suelzer, M, Pfohl, B, Coryell, WA (1990). Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity. Archives of General Psychiatry 47, 809818.
Phillips, KA (2011). Body image and body dysmorphic disorder. In Body Image: A Handbook of Science, Practice, and Prevention, 2nd edn (ed. Cash, T. F. and Smolak, L.), pp. 305313. Guilford Press: New York.
Phillips, KA, Albertini, RS, Siniscalchi, JM, Khan, A, Robinson, M (2001). Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. Journal of Clinical Psychiatry 62, 721727.
Phillips, KA, Diaz, SF (1997). Gender differences in body dysmorphic disorder. Journal of Nervous and Mental Disease 185, 570577.
Phillips, KA, Didie, ER, Feusner, J, Wilhelm, S (2008). Body dysmorphic disorder: treating an underrecognized disorder. American Journal of Psychiatry 165, 11111118.
Phillips, KA, Grant, JE, Siniscalchi, JM, Stout, R, Price, LH (2005 a). A retrospective follow-up study of body dysmorphic disorder. Comprehensive Psychiatry 46, 315321.
Phillips, KA, Hollander, E, Rasmussen, SA, Aronowitz, BR, DeCaria, C, Goodman, WK (1997). A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacology Bulletin 33, 1722.
Phillips, KA, McElroy, SL, Keck, PE, Pope, HG, Hudson, JI (1994). A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacology Bulletin 30, 179186.
Phillips, KA, Menard, W (2006). Suicidality in body dysmorphic disorder: a prospective study. American Journal of Psychiatry 163, 12801282.
Phillips, KA, Menard, W, Fay, C, Pagano, ME (2005 b). Psychosocial functioning and quality of life in body dysmorphic disorder. Comprehensive Psychiatry 46, 254260.
Phillips, KA, Menard, W, Fay, C, Weisberg, R (2005 c). Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 46, 317325.
Phillips, KA, Menard, W, Pagano, ME, Fay, C, Stout, RL (2006 a). Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. Journal of Psychiatric Research 40, 95104.
Phillips, KA, Pagano, ME, Menard, W, Fay, C, Stout, RL (2005 d). Predictors of remission from body dysmorphic disorder: a prospective study. Journal of Nervous and Mental Disease 193, 564567.
Phillips, KA, Pagano, ME, Menard, W, Stout, RL (2006 b). A 12-month follow-up study of the course of body dysmorphic disorder. American Journal of Psychiatry 163, 907912.
Phillips, KA, Wilhelm, S, Koran, LM, Didie, ER, Fallon, B, Fuesner, J, Stein, DJ (2010). Body dysmorphic disorder: some key issues for DSM-V. Depression and Anxiety 27, 573591.
Rief, W, Buhlmann, U, Wilhelm, S, Borkenhagen, A, Brahler, E (2006). The prevalence of body dysmorphic disorder: a population-based survey. Psychological Medicine 36, 877885.
Schwartz, RC, Cohen, BN, Grubaugh, A (1997). Does insight affect long-term inpatient treatment outcome in chronic schizophrenia? Comprehensive Psychiatry 38, 283288.
Shea, MT, Stout, RL, Yen, S, Pagano, ME, Skodol, AE, Morey, LC, Gunderson, JG, McGlashan, TH, Grilo, CM, Sanislow, CA, Bender, DS, Zanarini, MC (2004). Associations in the course of personality disorders and Axis I disorders over time. Journal of Abnormal Psychology 113, 499508.
Shea, MT, Yen, S (2003). Stability as a distinction between Axis I and Axis II disorders. Journal of Personality Disorders 17, 373386.
Soskis, DA, Bowers, MB (1969). The schizophrenic experience. A follow-up study of attitude and posthospital adjustment. Journal of Nervous and Mental Disease 149, 443449.
Steketee, G, Perry, JC, Goisman, RM, Warshaw, MG, Massion, AO, Peterson, LG, Langford, L, Weinshenker, N, Farreras, IG, Keller, MB (1997). The Psychosocial Treatment Interview for anxiety disorders: a method for assessing psychotherapeutic procedures in anxiety disorders. Journal of Psychotherapy Practice and Research 6, 194210.
Warshaw, MG, Keller, MB, Stout, RL (1994). Reliability and validity of the Longitudinal Interval Follow-up Evaluation for assessing outcome of anxiety disorders. Journal of Psychiatric Research 28, 531545.
Wilhelm, S, Otto, MW, Lohr, B, Deckersbach, T (1999). Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behaviour Research and Therapy 37, 7175.
Wilhelm, S, Phillips, KA, Fama, JM, Greenberg, JL, Steketee, G (2011). Modular cognitive-behavioral therapy for body dysmorphic disorder. Behavior Therapy 42, 624633.
Yonkers, KA, Bruce, SE, Dyck, IR, Keller, MB (2003). Chronicity, relapse, and illness – course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depression and Anxiety 17, 173179.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed